Loading...
Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer.
Palmieri, C Misra, Vivek Januszewski, A Yosef, H Ashford, R Keary, I Davidson, N
Palmieri, C
Misra, Vivek
Januszewski, A
Yosef, H
Ashford, R
Keary, I
Davidson, N
Citations
Altmetric:
Abstract
This study aimed to investigate the use of nonpegylated liposomal doxorubicin (NPLD) in the management of metastatic breast cancer (MBC) within routine UK clinical practice and to assess its efficacy and tolerability.
Description
Date
2014-04
Publisher
Collections
Keywords
Type
Article
Citation
Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer. 2014, 14 (2):85-93 Clin Breast Cancer